Literature DB >> 33788271

Antigen-dependent multistep differentiation of T follicular helper cells and its role in SARS-CoV-2 infection and vaccination.

Dirk Baumjohann1, Nicolas Fazilleau2,3.   

Abstract

T follicular helper (Tfh) cells play an essential role in regulating the GC reaction and, consequently, the generation of high-affinity antibodies and memory B cells. Therefore, Tfh cells are critical for potent humoral immune responses against various pathogens and their dysregulation has been linked to autoimmunity and cancer. Tfh cell differentiation is a multistep process, in which cognate interactions with different APC types, costimulatory and coinhibitory pathways, as well as cytokines are involved. However, it is still not fully understood how a subset of activated CD4+ T cells begins to express the Tfh cell-defining chemokine receptor CXCR5 during the early stage of the immune response, how some CXCR5+ pre-Tfh cells enter the B-cell follicles and mature further into GC Tfh cells, and how Tfh cells are maintained in the memory compartment. In this review, we discuss recent advances on how antigen and cognate interactions are important for Tfh cell differentiation and long-term persistence of Tfh cell memory, and how this is relevant to the current understanding of COVID-19 pathogenesis and the development of potent SARS-CoV-2 vaccines.
© 2021 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.

Entities:  

Keywords:  Antibody formation; T cells; antigen; differentiation; memory

Year:  2021        PMID: 33788271     DOI: 10.1002/eji.202049148

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells.

Authors:  Jennifer S Chen; Ryan D Chow; Eric Song; Tianyang Mao; Benjamin Israelow; Kathy Kamath; Joel Bozekowski; Winston A Haynes; Renata B Filler; Bridget L Menasche; Jin Wei; Mia Madel Alfajaro; Wenzhi Song; Lei Peng; Lauren Carter; Jason S Weinstein; Uthaman Gowthaman; Sidi Chen; Joe Craft; John C Shon; Akiko Iwasaki; Craig B Wilen; Stephanie C Eisenbarth
Journal:  Sci Immunol       Date:  2022-02-04

Review 2.  mRNA COVID-19 Vaccines and Long-Lived Plasma Cells: A Complicated Relationship.

Authors:  Girolamo Giannotta; Nicola Giannotta
Journal:  Vaccines (Basel)       Date:  2021-12-20

Review 3.  T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination.

Authors:  Marios Koutsakos; Wen Shi Lee; Adam K Wheatley; Stephen J Kent; Jennifer A Juno
Journal:  J Leukoc Biol       Date:  2021-11-03       Impact factor: 6.011

4.  Antigen-Specific CD4+ T-Cell Activation in Primary Antibody Deficiency After BNT162b2 mRNA COVID-19 Vaccination.

Authors:  Kai M T Sauerwein; Christoph B Geier; Roman F Stemberger; Hüseyin Akyaman; Peter Illes; Michael B Fischer; Martha M Eibl; Jolan E Walter; Hermann M Wolf
Journal:  Front Immunol       Date:  2022-02-14       Impact factor: 7.561

5.  Secreted heat shock protein gp96-Ig and OX40L-Fc combination vaccine enhances SARS-CoV-2 Spike (S) protein-specific B and T cell immune responses.

Authors:  Laura Padula; Eva Fisher; Katelyn Rivas; Kristin Podack; Daniela Frasca; Jonah Kupritz; Matthew M Seavey; Padmini Jayaraman; Eric Dixon; Rahul Jasuja; Natasa Strbo
Journal:  Vaccine X       Date:  2022-08-03

Review 6.  T cells in SARS-CoV-2 infection and vaccination.

Authors:  Arthur Young
Journal:  Ther Adv Vaccines Immunother       Date:  2022-08-24

Review 7.  A systematic review of current status and challenges of vaccinating children against SARS-CoV-2.

Authors:  Mengxin Zhang; Pin Zhang; Ying Liang; Bang Du; Lifeng Li; Zhidan Yu; Huanmin Wang; Qionglin Wang; Xianwei Zhang; Wancun Zhang
Journal:  J Infect Public Health       Date:  2022-10-13       Impact factor: 7.537

8.  OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccines.

Authors:  Rebekka Duhen; Michael Beymer; Shawn M Jensen; Srinivas Abbina; Suraj Abraham; Nikita Jain; Anitha Thomas; Andrew J Geall; Hong-Ming Hu; Bernard A Fox; Andrew D Weinberg
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.